Russell Investments Group Ltd. boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,132,218 shares of the healthcare conglomerate’s stock after buying an additional 120,487 shares during the period. UnitedHealth Group comprises approximately 0.7% of Russell Investments Group Ltd.’s holdings, making the stock its 15th largest position. Russell Investments Group Ltd. owned approximately 0.22% of UnitedHealth Group worth $395,392,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. Jackson Grant Investment Advisers Inc. raised its stake in shares of UnitedHealth Group by 0.4% in the first quarter. Jackson Grant Investment Advisers Inc. now owns 1,097 shares of the healthcare conglomerate’s stock valued at $180,000 after buying an additional 4 shares in the last quarter. Adirondack Trust Co. raised its stake in shares of UnitedHealth Group by 0.5% in the first quarter. Adirondack Trust Co. now owns 990 shares of the healthcare conglomerate’s stock valued at $162,000 after buying an additional 5 shares in the last quarter. RB Capital Management LLC raised its stake in shares of UnitedHealth Group by 0.4% in the second quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock valued at $321,000 after buying an additional 7 shares in the last quarter. Altfest L J & Co. Inc. raised its stake in shares of UnitedHealth Group by 0.3% in the second quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock valued at $549,000 after buying an additional 10 shares in the last quarter. Finally, Parkside Financial Bank & Trust raised its stake in shares of UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares in the last quarter. 86.21% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Incorporated (NYSE:UNH) traded down 0.20% during midday trading on Friday, reaching $194.36. The company’s stock had a trading volume of 1,374,959 shares. The stock has a market capitalization of $187.92 billion, a price-to-earnings ratio of 23.35 and a beta of 0.64. The firm has a 50-day moving average price of $191.39 and a 200 day moving average price of $177.02. UnitedHealth Group Incorporated has a 52-week low of $132.39 and a 52-week high of $196.04.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The firm had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. During the same period in the prior year, the company posted $1.96 EPS. The company’s revenue was up 7.7% on a year-over-year basis. Equities research analysts predict that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th will be given a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a dividend yield of 1.54%. The ex-dividend date of this dividend is Thursday, September 7th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.13%.

ILLEGAL ACTIVITY NOTICE: “UnitedHealth Group Incorporated (UNH) Shares Bought by Russell Investments Group Ltd.” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another website, it was stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this story can be read at https://www.thecerbatgem.com/2017/08/26/unitedhealth-group-incorporated-unh-shares-bought-by-russell-investments-group-ltd.html.

Several analysts recently weighed in on the company. Cantor Fitzgerald reissued a “buy” rating and issued a $205.00 price objective on shares of UnitedHealth Group in a report on Friday, July 7th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $190.00 target price on shares of UnitedHealth Group in a report on Monday, July 10th. Credit Suisse Group reaffirmed an “outperform” rating and set a $200.00 target price (up from $195.00) on shares of UnitedHealth Group in a report on Thursday, July 13th. Citigroup Inc. upped their target price on UnitedHealth Group from $195.00 to $213.00 and gave the company a “buy” rating in a report on Wednesday, July 19th. Finally, Royal Bank Of Canada reaffirmed a “buy” rating and set a $212.00 target price on shares of UnitedHealth Group in a report on Thursday, July 20th. One equities research analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $203.41.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $182.64, for a total transaction of $913,200.00. Following the completion of the sale, the director now directly owns 75,735 shares in the company, valued at $13,832,240.40. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Richard T. Burke sold 15,000 shares of the stock in a transaction on Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the sale, the director now owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 30,540 shares of company stock valued at $5,748,970. 0.89% of the stock is currently owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.